University of Ioannina
The role of microRNAs in Non-Hodgkin Lymphomas: association with prognosis and response to treatment
Abstract
dc:descriptionLarge B-cell lymphoma (LBCL) remains a biologically and clinically heterogeneous disease, with a substantial proportion of patients experiencing relapse or refractory disease despite standard immunochemotherapy regimens such as R-CHOP. Prognosis is primarily based on the International Prognostic Index (IPI) and selected biological markers, including cell-of-origin classification (GCB/ABC) and MYC/BCL2 double expression. Nevertheless, there is an ongoing need for novel, non-invasive, and reliable biomarkers. MicroRNAs (miRNAs) are small (~22-nucleotide) regulatory molecules that modulate gene expression at the post-transcriptional level, and circulating miRNAs have been proposed as potential diagnostic and prognostic biomarkers in LBCL. Objective: The aim of this study was to evaluate serum expression levels of miR-155-3p, miR-142-3p, and miR-22-3p at diagnosis and to investigate their associations with clinicopathological parameters and overall survival (OS). Patients and Methods: Serum samples were prospectively collected and analyzed from 45 newly diagnosed LBCL patients (age range 34–84 years; 26 males) treated at our center over a 4.5-year period, and from 26 healthy controls. All patients received immunochemotherapy. RNA isolation was performed using the miRNeasy Serum/Plasma Kit, and cDNA synthesis was performed using the TaqMan Advanced miRNA cDNA Synthesis Kit (Applied Biosystems). Quantitative RT-PCR was conducted on a LightCycler 480 platform using TaqMan™ Advanced miRNA assays for miR-155-3p, miR-142-3p, and miR-22-3p. Exogenous spike-in Ath-miR-159 from Arabidopsis thaliana was used for normalization, and all samples were analyzed in duplicate. The 25th and 75th percentiles of controls were used as cutoffs for low and high expression. Statistical analyses included Mann–Whitney U and χ² tests, Kaplan–Meier survival analysis with log-rank testing, and multivariable Cox proportional hazards modeling for variables with p<0.05 in univariable analysis (SPSS v29). Results: The median patient age was 67 years (58% male), with a median follow-up of 26 months; 13 patients died during the study period. Serum miR-155-3p and miR-142-3p levels did not differ significantly between patients and controls, whereas miR-22-3p was significantly elevated in LBCL patients (p<0.001). Low miR-142 expression was associated with increased MYC expression (p=0.023) and a lower frequency of the non-GCB phenotype (p=0.026), while high miR-22 expression was more common in non-GCB cases (p=0.046). In univariable analysis, B symptoms, serum albumin <3.5 g/dL, IPI score 3–5, hyponatremia, neutropenic fever, high serum miR-155-3p expression, and low serum miR-142-3p expression were associated with inferior OS. Multivariable analysis confirmed high miR-155-3p expression (HR 6.24, p=0.017) and low miR-142-3p expression (HR 7.52, p=0.01) as independent adverse prognostic factors for OS. Conclusions: Elevated serum miR-22-3p levels characterize patients with LBCL but are not associated with overall survival. In contrast, high miR-155-3p expression and low miR-142-3p expression represent independent adverse prognostic factors for OS, highlighting their potential utility as circulating biomarkers for risk stratification. Although preliminary due to the limited sample size, these findings warrant validation in larger, multicenter studies and further exploration of their integration into existing prognostic models.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koumpis, Andreas-Epameinondas
- Κουμπής, Ανδρέας-Επαμεινώνδας
Subjects
dc:subject × 15Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61771